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Background: Understanding the pattern of mortality linked to end stage renal disease (ESRD) is important
given the increasing ageing population in low- and middle-income countries.
Methods: We analyzed older patients with ESRD with incident hemodialysis, from January 2012 to August
2017 in one large general hospital in Peru. Individual and health system-related variables were analyzed using
Generalized Linear Models (GLM) to estimate their association with in-hospital all-cause mortality. Relative risk
(RR) with their 95% confidence intervals (95% CI) were calculated.
Results: We evaluated 312 patients; mean age 69 years, 93.6% started hemodialysis with a transient central
venous catheter, 1.7% had previous hemodialysis indication and 24.7% died during hospital stay. The mean
length of stay was 16.1 days (SD 13.5). In the adjusted multivariate models, we found higher in-hospital mor-
tality among those with encephalopathy (aRR 1.85, 95% CI 1.21-2.82 vs. without encephalopathy) and a low-
er in-hospital mortality among those with eGFR ≤7mL/min (aRR 0.45, 95% CI 0.31-0.67 vs. eGFR>7mL/min).
Conclusions: There is a high in-hospital mortality among older hemodialysis patients in Peru. The presence of
uremic encephalopathy was associated with higher mortality and a lower estimated glomerular filtration rate
with lower mortality.
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Introduction
The number of patients with end-stage renal disease (ESRD) in
renal replacement therapy has substantially increased world-
wide, and it is expected to grow further.1 In 2010, there were
2,618 million people with ESRD in the world, and it is projected
to increase to 5,439 million people in 2030, hemodialysis being
the main type of renal replacement therapy.1, 2 One of the rea-
sons for the increase in patients in hemodialysis is the growing
inclusion of older adults in renal replacement therapy.3
The number of older people is increasing worldwide along-
side chronic non-communicable diseases associated to ESRD
such as diabetes and hypertension, conditions that are also very
common in this age group, particularly in low- and middle-
income countries (LMIC).4 Kidney transplantation is the treat-
ment of choice in ESRD irrespective of age, yet hemodialysis
remains the most used therapy.5
Survival of older patients (i.e. >60 years old) in hemodialysis is
poor, an effect of several factors including age and late referral to
specialized nephrology care.6, 7 In addition to individual clinical
variables, inadequate pre-hemodialysis care is strongly associated
with higher mortality in older patients in hemodialysis.8 Most stud-
ies exploring the effect of pre-hemodialysis care on mortality and
its associated factors have typically included prevalent rather than
incident cases, thus limiting the evaluation of the effect on early
mortality of pre-hemodialysis care on incident patients.9
Health systems in many in LMIC face major burdens, and
their preparedness to serve patients in hemodialysis is not
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always optimal. Peru is a country with a high ageing index of
35.7%, which is the number of persons 60 years old or over per
hundred persons under age 15,10 and the public national health
system does not have adequate and effective strategies for pre-
hemodialysis care, including older adults.11, 12 As such, charac-
terizing the mortality of older patients in hemodialysis and its
associated factors will inform and improve health system-level
responses oriented to address the challenges imposed by ESRD
and hemodialysis in resource limited settings.
Methods
Study design and setting
We analyzed a data set of incident hemodialysis older patients
with ESRD, attending the 2 de Mayo General Hospital in Lima,
Peru’s capital with nearly 10 million inhabitants. Peru has a frag-
mented health care system where two institutions provide renal
replacement therapy: The Ministry of Health, the largest public
health care provider in the country, and the Social Security sys-
tem managed by the Ministry of Labor. In 2014, the Ministry of
Health offered hemodialysis to 1,983 individuals.13 2 de Mayo
General Hospital is one of the tertiary care hospitals from the
Ministry of Health, covering close to 0.5 million visits in the out-
patient services annually.
Data source
The hemodialysis data set included 663 patients over 18 years old.
Those over 60 years were 319. Were excluded 7 patients for miss-
ing mortality data; therefore, 312 patients were included in the
analysis (Figure 1). This data set is an in-hospital registry of
patients in hemodialysis of the 2 de Mayo General Hospital. While
they remain hospitalized, patients receive hemodialysis exclusively
in the nephrology service by nephrologists of the hospital. The data
set includes demographics, date of admission and discharge, dis-
charge status (dead or alive), etiology of ESRD and inpatient
laboratory information. Individual’s ≥60 years were defined as old-
er adults, according to the World Health Organization.14 Previous
nephrologist consultation was defined as at least two assessments
in the last year by any nephrologist.
We included data about time of ESRD diagnosis, if the patient
started hemodialysis by using a transient catheter to dialyze, if
had no previous nephrologist consultation and the presence of
uremic symptoms as criteria to initiate hemodialysis. We also
included pre-hemodialysis laboratory values: serum potassium,
pH, bicarbonate, hemoglobin, calcium, phosphorus, and the esti-
mated glomerular filtration rate. Estimated glomerular filtration
rate (eGFR), calculated using the MDRD4 formula,15 was cate-
gorized as follows:>7mL/min, and ≤7mL/min.16 All patients
started hemodialysis in different times in a period between
January 2012 and October 2017. We considered in-hospital all-
cause mortality as primary outcome.
Data analysis
Categorical data were summarized as frequencies and percen-
tages. Continuous variables were summarized as mean and
standard deviation (SD), except when the variable show skew
distribution, we summarized as medians and interquartile
ranges (IQR). Differences between two groups were tested with
Chi square test for categorical variables, and the Wilcoxon rank
sum test for continuous variables. We calculated the relative risk
(RR) together with their 95% confidence intervals (CI) of inde-
pendent predictors for in-hospital all-cause mortality using
Poisson generalized linear models (GLM) with robust error stan-
dards. Independent predictor variables, established confounding
variables for epidemiologic and clinical criteria were considered
in the multivariable GLM model. Unadjusted and age, sex, and
diabetes adjusted RR were reported. All the tests were 2-tailed,
and the type 1 error rate was set at 5%. Analyses were per-
formed with Stata 15.0 (Stata Corp, College Station, TX, USA).
Ethics statement
This study was conducted using non-identified data. The proto-
col of this study was approved by the Ethics Committee (Comité
Institucional de Ética en Investigación) of the Universidad
Peruana Cayetano Heredia in Lima, Peru; approval code number
096-05-17.
Results
We evaluated 312 patients, 195 (62.5%) males, mean age 69
years (SD±6.9, range 60-89). Diabetic nephropathy was the
most common etiology of ESRD and the most common indica-
tion for hemodialysis was encephalopathy. Only six (1.9%)
patients who start hemodialysis because of uremia symptoms
had a previous planned hemodialysis indication. Only 179
Figure 1. Flowchart of data included in the analysis.
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(57.4%) patients had a previous consultation by a nephrologist,
and 292 patients (93.6%) were dialyzed through a transient
central venous catheter. Table 1 shows the characteristics of the
study participants.
The mean length of stay was 16.1 days (SD: 13.5), and a
total of 77 (24.7%) patients died during the hospitalization peri-
od. The in-hospital all-cause mortality rate was 5.6 deaths per
1000 person-years (95% CI 4.5–7.0).
In the bivariable analysis, we found a strong association
between in-hospital all-cause mortality and encephalopathy
and uremic gastric affection as criteria to initiate hemodialysis
and also with an eGFR <7mL/min (Table 1).
In the multivariable models, having uremic encephalopathy
(vs. no) was associated with higher mortality, and a lower eGFR
(≤7 vs.>7mL/min) was associated with lower mortality (Table 2).
Discussion
We found that in-hospital all-cause mortality in older patients
with incident hemodialysis was high, with one in four older peo-
ple in hemodialysis dying during hospitalization. The presence of
uremic encephalopathy was associated with an increased risk of
death and an eGFR ≤7mL/min was associated with a lower
mortality risk in this population.
Our mortality rate was substantially higher than estimates
reported in a systematic review showing a median survival time
of 8–67 months;6 however, only one study of this systematic
review showed age ranges similar to our population and
reported a mortality rate of 10.3% also below our own.17 In our
study, we included incident patients, whilst the systematic
review6 only considered prevalent cases, hence our mortality
Table 1. Bivariable association between patient characteristics and gender or in-hospital mortality in ESRD older adults with incident
hemodialysis
Male Female p-value* Died Alive p-value** Total
(n=195) (n=117) (n=77) (n=235) (n=312)
General variables
Male 50 (64.9) 145 (61.7) 0.611 195 (62.5)
Female 27 (35.1) 90 (38.3)
Previous nephrologist consultation 47 (24.1) 34 (29.1) 0.334 20 (25.9) 61 (25.9) 0.998 81 (25.9)
Etiology of ESRD
Diabetic nephropathy 76 (38.9) 65 (55.6) 0.004 37 (48.1) 104 (44.3) 0.561 141 (45.2)
HTA nephroangiosclerosis 26 (13.3) 20 (17.1) 0.364 12 (15.6) 34 (14.5) 0.81 46 (14.7)
Chronic glomerulonephritis 6 (3.1) 5 (4.3) 0.579 7 (3.0) 4 (5.2) 0.36 11 (3.5)
Obstructive nephropathy 44 (22.6) 3 (2.6) 0.001 7 (9.1) 40 (17.0) 0.091 47 (15.1)
Renal polycystic disease 2 (1.1) 3 (2.6) 0.295 1 (1.3) 4 (1.7) 0.807 5 (1.6)
Non-classified 3 (1.8) 1 (1.1) 0.634 14 (18.2) 40 (17.0) 0.815 54 (17.3)
Time of ESRD diagnosis
Recent 93 (49.5) 38 (33.1) 0.019 36 (46.8) 95 (40.4) 0.657 131 (42.0)
1 to 6 months 44 (23.4) 28 (24.4) 15 (19.5) 57 (24.3) 72 (23.1)
6 to 12 months 16 (8.5) 18 (15.6) 9 (11.7) 25 (10.6) 34 (10.9)
>1 year 35 (18.6) 31 (26.9) 14 (21.9) 52 (26.0) 66 (25.0)
Criteria to initiate HD
Encephalopathy 115 (58.9) 64 (54.7) 0.461 55 (71.4) 124 (52.8) 0.004 179 (57.4)
Uremic gastric affection 60 (30.7) 41 (35.1) 0.435 14 (18.2) 87 (37.0) 0.002 101 (32.4)
Pericarditis 2 (1.1) 1 (0.9) 0.881 1 (1.3) 2 (0.9) 0.727 3 (1.0)
Pulmonary edema 44 (22.6) 34 (29.1) 0.201 19 (24.7) 59 (25.1) 0.94 78 (25.0)
Acidosis 82 (42.1) 32 (27.4) 0.009 28 (36.4) 86 (36.6) 0.971 114 (36.5)
Hyperkalemia 60 (30.8) 15 (12.9) 0.001 18 (23.4) 57 (24.3) 0.876 75 (24.0)
Laboratory values at HD initiation
eGFR <7 (mL/min) 154 (79.4) 90 (77.6) 0.709 48 (62.3) 196 (84.1) <0.001 5.1 (2.9)
Potassium (mEq/L) 6.1 (0.1) 5.5 (0.1) 0.004 5.8 (1.4) 5.9 (1.5) 0.743 5.9 (1.5)
pH 7.2 (0.1) 7.1 (0.1) 0.269 7.16 (0.87) 7.16 (0.86) 0.991 7.16 (0.86)
Bicarbonate (mEq/L) 11.8 (0.6) 12.7 (0.5) 0.297 11.9 (5.7) 12.2 (8.4) 0.862 12.1 (7.8)
Hemoglobin (g/dL) 7.6 (0.2) 7.8 (0.2) 0.402 7.7 (1.9) 7.7 (2.3) 0.872 7.7 (2.2)
Calcium (mg/dL) 8.2 (0.5) 7.9 (0.2) 0.716 7.9 (1.3) 8.1 (5.6) 0.727 8.1 (4.9)
Phosphorus (mg/dL) 7.1 (0.2) 6.2 (0.2) 0.009 7.1 (2.5) 6.7 (2.7) 0.284 6.8 (2.6)
*p comparing sex, **p comparing survival
ESRD: end-stage renal disease, HD: hemodialysis, eGFR: estimated glomerular filtration rate
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rate could be higher than estimates reported among prevalent
cases. It has been reported that mortality within the first 3
months of initiating hemodialysis is higher, since it is a period of
adaptation to therapy.17–23 However, studying mortality among
incident patients allows an evaluation of the clinical conditions
in which the patient initiates hemodialysis which is indirectly
linked to the structure and delivery of health care.17–23
Our data showed that pre-hemodialysis care in our patients
was deficient, especially due to two predominant factors. First,
several patients initiated hemodialysis in an emergency way
using transient vascular access. Second, most patients did not
receive specialized consultation by a nephrologist. Both factors
have been reported to be associated with higher mortality in
other studies.24–31 However, the frequency of these factors is
similar among both groups according to death status; therefore,
there were no significant differences in the multivariate analysis.
Older adults who initiated hemodialysis have different health,
socioeconomic and functional status, cognitive and affective level
and different degrees of disease burden, malnutrition and
frailty.32 An adequate comprehensive geriatric assessment is the
best way to identify these conditions in the pre-hemodialysis per-
iod to improve survival33–36 and even provide tools to involve old-
er people in the decision-making process to decide for
hemodialysis or a conservative management.
In our population, a clinical aspect such uremic encephalop-
athy was related to higher mortality and other studies have also
found this association.22, 37 Uremic symptoms are more likely to
present in the average eGFR of patients (4.8mL/min)38 and it is
difficult to define39 and explain the discrepancies found as mor-
tality predictor.39–41 However, the presence of this symptom is
an indicator of the severity with our patients start hemodialysis
and the explaination of the association with a higher mortality.
Our finding that an eGFR ≤ 7mL/min was associated with a
lower mortality risk may be contradicting our description about
uremic encephalopathy. An explanation of this result is that a
lower GFR is an expression of a higher creatinine value, which
indirectly could be related to a greater muscle mass and there-
fore less malnutrition than the group that started hemodialysis
with lower creatinine level and higher GFR.42 The malnutrition
has been associated with greater mortality in hemodialysis
patients, which could be the reason for this association.43–45
There is a growing interest to determine the time to start
dialysis by a GFR level and its association with mortality. In
general population, the IDEAL study did not find that an early
start to dialysis, defined by a GFR > 10mL/min, was associated
with lower mortality.38 In older patients, there are no rando-
mized studies addressing this aspect; however, observational
studies had discrepant results. One study among patients older
than 67 years of the US Renal Data System, found that starting
dialysis with a GFR > 10mL/min was associated with higher
mortality.46 In contrast, a study made in Singapore found that
starting dialysis with a GFR > 10mL/min was not associated
with higher mortality in those over 65 years of age, unlike
younger patients.47
Our study has some limitations. Our database did not include
variables such as coronary disease, smoking, obesity; however,
the all-cause mortality rate is mainly due to cardiovascular mor-
tality and those risk factors are very prevalent in ESRD popula-
tion.48 The database did not include other geriatric variables
such as functionality, cognitive level and frailty, all of them asso-
ciated with morbidity and mortality in older adults who initiate
hemodialysis but those conditions were associated with mortal-
ity in prevalent patients rather than in incident population.36 In
the analysis, we excluded some variables with a high number of
missing data; for example, serum albumin, sodium and chloride
as electrolyte balance, however, the rest of variables included
had more than 80% of data capture. This database was derived
at a national reference hospital with one of the largest nephrol-
ogy units of the Ministry of Health in Peru, and thus affords a
reasonable scoping of hemodialysis in Peru and similar LMIC
health systems.
In conclusion, there is a high in-hospital all-cause mortality
among older population attending public hospitals in Peru. Uremic
encephalopathy is associated with higher mortality and an eGFR
≤ 7mL/min is associated to lower in-hospital mortality in this popu-
lation. A correct and complete assessment of pre-hemodialysis care
in elderly people, a health system quality indicator, should be a pri-
ority in low- and middle-income countries. Policies for early detec-
tion and timely management of older ESRD patients considering a
comprehensive assessment should be designed.
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